Phase I study of the heat shock protein 90 inhibitor...

Leukemia 2010 Vol. 24; Iss. 4

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

Lancet, J E, Gojo, I, Burton, M, Quinn, M, Tighe, S M, Kersey, K, Zhong, Z, Albitar, M X, Bhalla, K, Hannah, A L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Year:
2010
Language:
english
Pages:
7
DOI:
10.1038/leu.2009.292
File:
PDF, 337 KB
english, 2010
Conversion to is in progress
Conversion to is failed